Dental Anxiety, Dental Pain, Essential Oil
Conditions
Keywords
Dental Anxiety, Dental Pain, Emotional changes, Olfaction, Essential Oil, Lavender
Brief summary
the objective of this study is to evaluate the ability of olfaction in obtaining positive emotional and behavioral responses toward dental anxiety and pain in patients undergoing different dental procedures.
Detailed description
All patients who meet inclusion criteria of the study will be given a written consent and enrolled into a randomized double-blinded controlled study (investigator and patients are blinded about the study). Patients will be divided into lavender and control groups. Patients in lavender group will subjected 2 % lavender vapors. In control group, patients will inhale distal water vapors
Interventions
Lavender will be inhaled through three phases
Vapors of the distal water will be inhaled through three phases
Sponsors
Study design
Masking description
The randomization will be performed according to patients' sequences where all odd numbers of patients will be incorporated into control group, while even numbers will be included in lavender group. The patients will not be informed about the type of the essential oil. T This was achieved by inserting lavender vaporizers in all setting rooms and clinics. So that the patients will believe that there is no extraordinary maneuver in the clinics. Also, all the dentists who treated the patients and evaluators who will interview the patients and questionnaires, will not be informed of the type of the essential oil which will be used. The statistician who will analyze the questionnaires will be informed that the study's groups are named as group A or B.
Intervention model description
The patients will be divided into a control group in which the patients will be subjected to vapors of plain distal water, and lavender group where the patients will inhale vapors of the lavender oil to stimulate olfaction
Eligibility
Inclusion criteria
1. Adult females over 18 years, 2. Attending morning sessions of clinics (9 am) 3. Liable for administration of local anesthesia, tooth preparation either for filling procedures or crown preparations, endodontic treatment, teeth extraction, or subgingival scaling
Exclusion criteria
1. Males 2. Females who had allergies, bronchial asthma, common cold, pulmonary diseases, migraine, or taking antidepressants, anxiolytic drugs, opioids, or other medications that affect our results
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Anxiety score | 20 minutes before exposure to vapors | This is calculated by assigning scores of 0, 1, 2, and 3 to the response categories, respectively, of not at all, several days, more than half the days, and nearly every day. GAD-7 total score for the seven items ranges from 0 to 21. 0-4: minimal anxiety 5-9: mild anxiety 10-14: moderate anxiety 15-21: severe anxiety |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Pain Score | 20 minutes before exposure to vapors | A person rates their pain on a scale of 0 to 10 Zero means no pain, 1 to 3 means mild pin 4 to 6 means moderate pain 7 to 10 means severe pain |
Countries
Saudi Arabia